Christopher Tapper

Christopher Tapper is a seasoned professional with extensive experience in the life sciences and biopharmaceutical sectors. Currently serving as a Board Observer for multiple organizations including Carrick Therapeutics, Epitopea, Microbiotica, Exvastat, and Mosaic Therapeutics, Christopher's focus is on advancing cancer therapies and innovative treatments. In addition, Christopher holds the position of Senior Investment Associate at Cambridge Innovation Capital, where involvement centers on supporting leading life sciences and technology companies. Previous roles include External Innovations Manager and Strategy Manager at C4X Discovery Ltd, as well as various positions at L.E.K. Consulting and a research assistant role at the Centre for Public Health in Northern Ireland, contributing to significant research initiatives.